<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="Recent Updates on Mouse Models for Human Immunodeficiency, Influenza, and" exact="Dengue" post="Viral Infections KrishnakumarVinodhini1†DurairajanSiva Sundara Kumar1*†https://orcid.org/0000-0003-1401-8589AlagarasuKalichamy2LiMin3*DashAditya Prasad4[1], kvinodhini@cutn.ac.in[2], alagarasu@gmail.com[3], [4],"/>
 <result pre="in human peripheral blood mononuclear cells in vivo [99]. 4." exact="Dengue" post="Virus (DENV) Dengue is a vector-borne viral illness in"/>
 <result pre="blood mononuclear cells in vivo [99]. 4. Dengue Virus (DENV)" exact="Dengue" post="is a vector-borne viral illness in humans, and it"/>
 <result pre="Half of the world’s population is at risk for infection." exact="Dengue" post="virus (DENV) belongs to the family Flaviviridae and is"/>
 <result pre="the family Flaviviridae and is closely related to hepatitis C," exact="West Nile," post="Zika, [100] and Japanese encephalitis viruses. These family virus"/>
 <result pre="countries [102]. Availability of an appropriate small animal model for" exact="DENV" post="infection has been, and remains, a challenge. 4.1. Knockout"/>
 <result pre="been, and remains, a challenge. 4.1. Knockout Mouse Models of" exact="DENV" post="At the beginning of the 20th century, researchers struggled"/>
 <result pre="al. [105] first tested the utility of AG129 mice in" exact="DENV" post="vaccine trials. Their study reported that AG129 mice infected"/>
 <result pre="(D220) are being considered as an improved model to study" exact="DENV" post="infection and disease and for testing vaccines and antivirals,"/>
 <result pre="highlighted the role of the STAT-1 and STAT-2 protein in" exact="DENV" post="biology [109,110]. Mice lacking either STAT-1 or STAT-2 infected"/>
 <result pre="biology [109,110]. Mice lacking either STAT-1 or STAT-2 infected with" exact="DENV" post="possess a higher level of viral RNA compared to"/>
 <result pre="STAT2-dependent pathway in mediating transcription of the interferon-stimulated genes against" exact="DENV" post="in the absence of STAT-1 [111]. Mice lacking IFN"/>
 <result pre="(IRF)-3 and -7 have been shown to be infected with" exact="DENV" post="by the bite of infectious mosquitoes; infected mice were"/>
 <result pre="model is being used to understand the transmission dynamics of" exact="DENV" post="[112]. Triple KO mice lacking IRF-3, -5, and -7,"/>
 <result pre="in inducing IFN-γ, as well type I IFN, responses against" exact="DENV" post="[113]. Moreover, quadruplet KO mice-based experiments have revealed the"/>
 <result pre="role of this alternative pathway involving IRF-1 in resistance to" exact="DENV" post="[113]. The pathogenic role of CCR5, a chemokine receptor,"/>
 <result pre="to demonstrating the involvement of several cellular signalling pathways in" exact="DENV" post="infection. 4.2. Transgenic Mouse Models of DENV Transgenic mice"/>
 <result pre="signalling pathways in DENV infection. 4.2. Transgenic Mouse Models of" exact="DENV" post="Transgenic mice over-expressing human tumor necrosis factor (TNF)-α have"/>
 <result pre="to demonstrate the role of TNF-α in the development of" exact="DENV" post="encephalitis-like symptoms and neurotoxicity. Moreover, anti TNF-α antibodies reduced"/>
 <result pre="[115]. Since mice lacking the IFN-α/β receptor are susceptible to" exact="DENV" post="infection and demonstrate T cell responses against DENV infection,"/>
 <result pre="susceptible to DENV infection and demonstrate T cell responses against" exact="DENV" post="infection, studying T cell responses in the context of"/>
 <result pre="relevant to vaccine design [110]. 4.3. Humanized Mouse Models of" exact="DENV" post="Human cell responses to DENV infection can be studied"/>
 <result pre="4.3. Humanized Mouse Models of DENV Human cell responses to" exact="DENV" post="infection can be studied better in humanized mouse models"/>
 <result pre="human cord blood hematopoietic progenitor (CD34+) cells and infected with" exact="DENV" post="mimicking natural infection conditions have been used to demonstrate"/>
 <result pre="an attractive platform for assessing human immune responses to the" exact="DENV" post="vaccine [121,122]. However, humanized mice models predominantly develop IgM"/>
 <result pre="However, humanized mice models predominantly develop IgM in response to" exact="DENV" post="infection; only a few developed an IgG response because"/>
 <result pre="the observed results: (i) to test the safety of the" exact="DENV" post="vaccine in the recipient without pathology [120,127]; and (ii)"/>
 <result pre="pathology [120,127]; and (ii) to test the immunogenicity of the" exact="DENV" post="vaccine [126,128,129]. 5. Conclusions Indeed, it is not easy"/>
 <result pre="virus-specific CD8+ T cellsJ. Immunol.20091824865487310.4049/jimmunol.080197419342665 111.PerryS.T.BuckM.D.LadaS.M.SchindlerC.ShrestaS.STAT2 mediates innate immunity to" exact="Dengue" post="virus in the absence of STAT1 via the type"/>
 <result pre="FABP5. Anti inflammatory response against H1N1 influenza A [79] 3." exact="Dengue" post="129Sv(ev) (AG129 KO) Type I&amp;amp; II- IFN receptors deficient."/>
 <result pre="7 Antiviral role of IRF-1 by indcuing IFN responses against" exact="DENV" post="infection [113] viruses-11-00252-t002_Table 2Table 2 Transgenic mouse models for"/>
 <result pre="and control of a viral zoonosis of influenza [84,85] 3." exact="Dengue" post="C57BL/6J Tg HLA-A*02:01 and B10. Tg. HLA-DR3 Geness coding"/>
 <result pre="NOD/Shi-SCID-IL2rγnull (NOG). Humanized with huPBMCs. Evaluating vaccine safety [99] 3." exact="Dengue" post="RAG2−/−γc−/− mice Xenografted with human CD34+ hematopoietic stem cells"/>
 <result pre="Xenografted with human CD34+ hematopoietic stem cells Antibody responses against" exact="DENV" post="[119] NOD-SCID IL2rγ null Transplanation of purified cord blood"/>
</results>
